🔴 Nasus Pharma is trading 5% down in pre-market with no confirmed catalyst

Nasus Pharma is trading 5.29% lower at $3.03, with no confirmed company announcement explaining the pre-market decline.

• The November 2 close was $3.20; a November 2 report noted a lower compiled analyst consensus price target.
• Maxim Group’s Buy initiation was reported October 30, but neither report establishes a direct link to the move. Broader market signals are mixed.